Aesthetic improvements are reported in 60–75% of participants in published series, but definitions of 'improvement' vary widely. Some studies use blinded photo assessment; others rely on patient self-reporting. Responders typically show modest gains—measurable skin firmness improvements and reduction in fine lines rather than dramatic reversal. Non-responders experience minimal visible change. Success depends heavily on baseline skin condition, age, and sun exposure history; outcomes are less predictable than surgical facelifts.
Nine registered clinical trials are currently tracking outcomes in aesthetic applications. Most focus on exosome infusions or fibroblast-derived serums applied topically or via micro-needling. Published studies report improvements in skin hydration, elasticity measurements, and subjective appearance scores over 8–12 weeks, though effect sizes vary. Placental extract trials have documented reductions in visible wrinkle depth in some cohorts. Evidence remains preliminary; long-term durability beyond 6 months is incompletely characterised. No major regulatory agency has approved stem cell-derived cosmetic products as therapeutic devices, though several are marketed as cosmeceuticals in jurisdictions with lighter oversight.
Am I a candidate? → · Aesthetic & Anti-Ageing: full overview → · Aesthetic & Anti-Ageing cost → · Cost →
Medically reviewed by StemCellAtlas’s editorial team with the Stem Plus medical team (physicians & scientists · GMP-certified Sofia laboratory · 25+ yrs international experience) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.
Médecine régénérative certifiée GMP au cœur de l'UE — à partir de 3 000–8 000 €, une fraction des prix américains ou allemands. Protocoles personnalisés pour patients de plus de 50 pays.
Évaluation médicale gratuite